Robert T O'Donnell is a notable inventor based in Sacramento, CA. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, O'Donnell's work focuses on utilizing fermented wheat germ proteins and novel peptide epitopes for therapeutic applications.

Latest Patents

One of O'Donnell's latest patents is centered around the use of fermented wheat germ proteins (FWGP) for the treatment of cancer. This invention provides compositions that include components of fermented wheat germ extract (FWGE) that are active in reducing, inhibiting, or preventing the proliferation of cancer cells and tumors. The active components from FWGE consist of polypeptides with a molecular weight ranging from about 5-100 kiloDaltons (kD), specifically between 12-50 kD. Additionally, O'Donnell has developed a patent for antigenic epitopes with Lym-1 reactivity. This invention introduces novel peptide epitopes recognized by the Lym-1 antibody, which can generate antibodies directed against B-NHL cells, thus contributing to the treatment of non-Hodgkin's B cell lymphoma.

Career Highlights

O'Donnell is affiliated with the University of California, where he conducts his research and develops his inventions. His work has garnered attention for its potential impact on cancer therapies, showcasing his commitment to advancing medical science.

Collaborations

Some of O'Donnell's notable coworkers include Larry M Rose and Claude F Meares. Their collaborative efforts have contributed to the development of innovative solutions in the field of cancer treatment.

Conclusion

Robert T O'Donnell's contributions to cancer research through his patented inventions highlight his role as a significant innovator in the medical field. His work continues to pave the way for advancements in cancer therapies, demonstrating the importance of innovation in healthcare.